Introduction {#s1}
============

Mechanical loading, and the associated mechanical stress, shows immense skeletal site-related variation [@pone.0010692-Lanyon1], [@pone.0010692-Rubin1]. A stark example of such profound differences in the extent of the mechanical loading is that of the lumbar spine (LS), where normally far greater loading is experienced than at such skeletal sites as skull or iliac crest (ILC) [@pone.0010692-Mannion1]. There are therefore marked differences in bone density, micoarchitecture and bone composition at different skeletal sites, which reflect evolutionary adaptation of the skeleton [@pone.0010692-Turner1]--[@pone.0010692-Aerssens1]. A focus of recent interest is how environmental and genetic factors influence bone mineral density (BMD). The genotypic influence on skeleton have largely been focused on the phenotype relating to bone density, and only a handful studies have investigated bone geometry or bone quality indirectly by looking at the risk of fracture [@pone.0010692-Peacock1]. Genetic factors influence bone mass and between 50--90% of variation in BMD is inherited [@pone.0010692-Peacock1]. These BMD determinants are known to be polygenic, and objective evidence for this is provided by candidate gene SNPs (single nucleotide polymorphisms), quantitative trait locus and family linkage studies [@pone.0010692-Peacock1]--[@pone.0010692-Reppe1]. Previous studies have identified multiple candidate genes and chromosomal regions which influence bone mass and are linked to osteoporosis-related phenotypes [@pone.0010692-Peacock2]--[@pone.0010692-Reppe1]. These studies have also provided evidence for the presence of gender- and skeletal site-specific regulation and variation of BMD [@pone.0010692-Peacock2]--[@pone.0010692-Reppe1]. However, the nature of polygenic influences and the resulting complexity of molecular interaction mediating these effects in the development, attainment and subsequent maintenance of bone mineral density (BMD) are unclear.

Bone is a heterogeneous tissue and its histological classification, based on macroscopic texture of cross sections, classifies the tissue into compact (or cortical) and cancellous (or trabecular) subtypes. The trabeculae, within cancellous bone, while may appear to be disorganized are in fact arranged to provide maximum strength and are aligned in the direction to support maximum mechanical stress. Trabecular bone has a porous network of irregular cavities, and being less dense than compact bone, constitutes only a small fraction of total bone mass, but provide approximately 90% of the total bone surface area representing about 80% of the exchangeable calcium pool. It is this much larger surface area that makes trabecular bone metabolically more active than compact bone. The question as to how mechanical loading, and the associated mechanical stress, affects particular histological type of bone at different sites in the skeleton is of interest. To date many studies have been performed examining the mechanical stress related changes in the bone strength, microarchitecture and even cellular changes [@pone.0010692-Lanyon1]--[@pone.0010692-Aerssens1]. The effect of differences in the mechanical loading on the underlying complex molecular architecture of bone, which is critical for bone function, has never been investigated. Therefore, to address this question we have performed a global gene transcriptome investigation on human male cancellous bone from two anatomical sites, exposed to marked differences in mechanical and functional demands.

Results {#s2}
=======

Raw data Analysis {#s2a}
-----------------

In view of high degree of molecular homogeneity in the overall transcript expression between these sites (\>95%), the data from the three lumbar vertebrae, namely L2, L3 and L4, were grouped for analysis ([Table S1](#pone.0010692.s001){ref-type="supplementary-material"}). If filtration on absents (or presents) is used to remove transcripts that have absent call in all the arrays then 40,450 transcripts were found, and the number of transcripts expressed in all of the bone biopsies is approximately 14,300. The Venn analysis revealed 9177 gene transcripts to be uniquely expressed in the LS as opposed to 713 gene transcripts in the ILC. A statistical comparison of global gene expression in lamina of lumbar vertebrae (L2, L3 and L4) and ILC revealed differential expression of 4244 gene transcripts with significant differences (fold change ≥2.0, p-value ≤0.05). It was seen that compared with ILC, in LS region 3406 transcripts were up-regulated and 838 were down regulated. However, the number of differentially expressed transcripts between the skeletal sites was found to be 1733 for an adjusted p-value \<0.05 and fold change \>2; 1025 probesets are up-regulated in LS versus ILC, 708 probesets are downregulated in LS compared to ILC. Examination of Gene Ontology (GO) terms show a statistically significant over representation for a number of GO terms (p\<0.005) including biological and cell adhesion, extracellular matrix formation and skeletal development ([Table S2](#pone.0010692.s002){ref-type="supplementary-material"}).

Bone cells related transcriptomes {#s2b}
---------------------------------

The detailed analysis of the data reveals some profound and consistent changes in the transcriptomes that are characteristically associated with skeletal tissues, which were up-regulated in the LS when compared with ILC ([Table 1](#pone-0010692-t001){ref-type="table"} & [2](#pone-0010692-t002){ref-type="table"}). Bone related genes, such as SOST, MEPE and matrix Gla protein were among the most up-regulated, but also novel and genes with uncharacterised gene function, such as Zic1, cDNA clone ZA88B06 and DKFZP434C153 protein showed high differential expression. The comparison of transcripts characteristically associated with osteoblasts, osteoclast and osteocytes, revealed profound difference between the ILC and LS ([Table 3](#pone-0010692-t003){ref-type="table"}). Interestingly, whilst transcripts of enzymes, matrix proteins and humoral factors, reflecting activities of osteoblasts, osteoclasts and osteocytes showed up-regulation in the LS, the cell structure components of these cells, namely PTHR2, CTR and PDPN, respectively, showed similar expression in both sites. The array data was validated by qRT-PCR of RNA from five ILC and equal number of randomly selected LS biopsies. The verification was carried out by determining expression of select group of differential expressed transcripts. The transcripts were selected to reflect respective expression activities of each of the three bone cell types, for osteoclast CATK, for osteoblast Col1α and for osteocytes SOST, DMP1 and MEPE ([Table 3](#pone-0010692-t003){ref-type="table"} & [4](#pone-0010692-t004){ref-type="table"}). The increased expression in the LS compared with ILC suggested increased transcriptional activity of the three bone cells rather than any changes in their numbers. OSCAR and PTHR2 expression seen in the array data were substantiated by qRT-PCR, which reflects lack of site-related significant differences in actual number of osteoclast and osteoblast respectively. Thus, the major molecular differences between the two distinct bone sites were strictly associated with osteocyte and osteoblast related transcripts encoding matrix (secretory) proteins and key master regulatory genes encoding transcription factors, e.g. RUNX2.

10.1371/journal.pone.0010692.t001

###### Top up-regulated genes showing up-regulation \>50 fold in lamina of lumbar vertebrae (LS) in comparison with iliac crest (ILC).

![](pone.0010692.t001){#pone-0010692-t001-1}

  Probe Set ID                                                           Gene Title                                                           Gene Symbol   p-value LS vs. ILC   FC Absolute LS vs. ILC   S.D
  -------------- --------------------------------------------------------------------------------------------------------------------------- ------------- -------------------- ------------------------ ------
  206373_at                                          zic1 family member (odd-paired homolog, Drosophia)                                          Zic1            8.95E-08                202.03           1.78
  217404_s\_at                  collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital)                   COL2A1            1.6E-5                 167.51           2.95
  205713_s\_at                                               cartilage oligomeric matrix protein                                                 COMP            1.08E-11                166.98           1.15
  209904_at                                                       troponin C type 1 (slow)                                                       TNNC1            0.003                  157.67           4.79
  206227_at                                 cartilage intermediate layer protein, nucleotide pyrophosphohydrolase                                CILP            6.84E-11                154.45           1.25
  214087_s\_at                                               myosin binding protein C, slow type                                                MYBPC1           1.87E-04                134.89           3.41
  204737_s\_at    myosin, heavy chain 6, cardiac muscle, alpha (cardiomyopathy, hypertrophic 1) myosin, heavy chain 7, cardiac muscle, beta   MYH6///MYH7         0.002                  112.49           4.18
  204810_s\_at                                                     creatine kinase, muscle                                                        CKM             0.002                  96.48            4.07
  209888_s\_at                                          myosin, light chain 1, alkali; skeletal, fast                                            MYL1            8.70E-04                84.64            3.58
  209742_s\_at                                        myosin, light chain 2, regulatory, cardiac, slow                                           MYL2             0.002                  82.85            3.88
  213201_s\_at                                               troponin T type 1 (skeletal, slow)                                                  TNNT1            0.002                  79.48            3.99
  209621_s\_at                                                      PDZ and LIM domain 3                                                        PDLIM3           3.82E-05                77.27            2.68
  213782_s\_at                                                           myozenin 2                                                              MYOZ2            0.002                  74.63            3.89
  212654_at                                                         tropomyosin 2 (beta)                                                         TPM2            3.23E-04                69.76            3.14
  213492_at                     collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital)                   COL2A1           4.40E-05                68.00            2.49
  222043_at                                                               Clusterin                                                               CLU            1.32E-09                62.26            1.31
  203872_at                                                    actin, alpha 1, skeletal muscle                                                   ACTA1           0.00307                 60.50            3.85
  219728_at                                                               Myotilin                                                               MYOT            8.21E-04                58.01            3.31
  205054_at                                                                Nebulin                                                                NEB             0.001                  57.24            3.31
  204179_at                                                               Myoglobin                                                               MB              0.001                  56.32            3.51
  228224_at                                         proline/arginine-rich end leucine-rich repeat protein                                        PRELP           2.74E-09                55.65            1.19
  219106_s\_at                                         kelch repeat and BTB (POZ) domain containing 10                                          KBTBD10           0.002                  50.02            3.41

FC, fold change; SD, standard deviation.

10.1371/journal.pone.0010692.t002

###### Selected skeletal genes showing significant up-regulation on expression in the lamina of lumbar vertebrae (LS) compared with iliac crest (ILC).

![](pone.0010692.t002){#pone-0010692-t002-2}

  Probe Set ID                               Gene Title                                             Gene Symbol                  *p-*value LS *vs. ILC*   FC Absolute LS *vs. ILC*   S.D.
  -------------- ------------------------------------------------------------------- ------------------------------------------ ------------------------ -------------------------- ------
  223869_at                                 Sclerosteosis                                               SOST                            1.90E-08                   40.79             1.35
  208175_s\_at                   dentin matrix acidic phosphoprotein                                    DMP1                            1.35E-05                   13.59             1.37
  221150_at       matrix, extracellular phosphoglycoprotein with ASARM motif (bone)                     MEPE                            2.60E-05                    9.22             1.30
  231766_s\_at                       collagen, type XII, alpha 1                      COL12A1[\*](#nt103){ref-type="table-fn"}          2.51E-04                   12.77             1.82
  231879_at                          collagen, type XII, alpha 1                      COL12A1[\*](#nt103){ref-type="table-fn"}          0.00182                    4.141             1.23
  225664_at                          collagen, type XII, alpha 1                      COL12A1[\*](#nt103){ref-type="table-fn"}          2.39E-07                   13.26             1.05
  209101_at                        connective tissue growth factor                                      CTGF                            2.41E-07                   11.77             1.05
  238481_at                              matrix Gla protein                             MGP[\*](#nt103){ref-type="table-fn"}            8.48E-07                   20.55             1.24
  202291_s\_at                           matrix Gla protein                             MGP[\*](#nt103){ref-type="table-fn"}            7.42E-09                   12.45             0.85
  232267_at                        G protein-coupled receptor 133                                      GPR133                           2.30E-10                   14.34             0.72
  219522_at                        four jointed box 1 (Drosophila)                                      FJX1                            8.63E-06                    7.75             1.02
  1561754_at                    Full length insert cDNA clone ZA88B06                                 ZA88B06                           1.41E-04                    4.05             0.93
  241902_at                                mohawk homeobox                              MKX[\*](#nt103){ref-type="table-fn"}            2.55E-04                    7.82             1.46
  239468_at                                mohawk homeobox                              MKX[\*](#nt103){ref-type="table-fn"}            5.28E-06                    6.55             0.88
  213591_at                  aldehyde dehydrogenase 7 family, member A1                               ALDH7A1                           5.40E-05                    8.08             1.24
  208950_s\_at               aldehyde dehydrogenase 7 family, member A1                               ALDH7A1                           5.76E-04                    2.22             0.60

FC, fold change; SD, standard deviation.

\*Multiple probe sets.

10.1371/journal.pone.0010692.t003

###### Comparison of differences in the absolute expression of osteoblast, osteoclast and osteocyte-related gene transcripts in lamina of lumbar vertebrae (LS) and iliac crest (ILC).

![](pone.0010692.t003){#pone-0010692-t003-3}

  Cell type      Probe Set ID                  Gene Symbol                                                          Gene Title                                             FC (LS vs. ILC)
  ------------- --------------- ----------------------------------------- ----------------------------------------------------------------------------------------------- -----------------
  Osteocytes     208175_s\_at                     DMP1                                                  dentin matrix acidic phosphoprotein                                     13.59
                   221150_at                      MEPE                                   matrix, extracellular phosphoglycoprotein with ASARM motif (bone)                      9.22
                   221166_at                      FGF23                                                     fibroblast growth factor 23                                         3.52
                   223869_at                      SOST                                                             sclerosteosis                                                40.79
                   204879_at      PDPN[\*](#nt105){ref-type="table-fn"}                                             podoplanin                                                  6.43
                   208233_at      PDPN[\*](#nt105){ref-type="table-fn"}                                             podoplanin                                                  2.82
                   221898_at      PDPN[\*](#nt105){ref-type="table-fn"}                                             podoplanin                                                  5.90
                   226658_at      PDPN[\*](#nt105){ref-type="table-fn"}                                             podoplanin                                                  2.75
  Osteoblasts    202310_s\_at    COL1A1[\*](#nt105){ref-type="table-fn"}                                     collagen, type I, alpha 1                                          6.13
                 202311_s\_at    COL1A1[\*](#nt105){ref-type="table-fn"}                                     collagen, type I, alpha 1                                          3.99
                 1556499_s\_at   COL1A1[\*](#nt105){ref-type="table-fn"}                                     collagen, type I, alpha 1                                          2.19
                   206956_at                      BGLAP                                       bone gamma-carboxyglutamate (gla) protein (osteocalcin)                           3.78
                 209875_s\_at                     SPP1                     secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1)        2.97
                   212667_at     SPARC[\*](#nt105){ref-type="table-fn"}                        secreted protein, acidic, cysteine-rich (osteonectin)                            5.86
                 200665_s\_at    SPARC[\*](#nt105){ref-type="table-fn"}                        secreted protein, acidic, cysteine-rich (osteonectin)                            4.01
                 209875_s\_at                     SPP1                     secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1)        2.97
                   207370_at      IBSP[\*](#nt105){ref-type="table-fn"}               integrin-binding sialoprotein (bone sialoprotein, bone sialoprotein II)                   3.97
                   236028_at      IBSP[\*](#nt105){ref-type="table-fn"}               Integrin-binding sialoprotein (bone sialoprotein, bone sialoprotein II)                   7.35
                   236859_at     RUNX2[\*](#nt105){ref-type="table-fn"}                                 runt-related transcription factor 2                                     3.80
                   221283_at     RUNX2[\*](#nt105){ref-type="table-fn"}                                 runt-related transcription factor 2                                     2.74
                 236858_s\_at    RUNX2[\*](#nt105){ref-type="table-fn"}                                 runt-related transcription factor 2                                     2.21
                   205289_at      BMP2[\*](#nt105){ref-type="table-fn"}                                    bone morphogenetic protein 2                                         2.71
                 205290_s\_at     BMP2[\*](#nt105){ref-type="table-fn"}                                    bone morphogenetic protein 2                                         2.60
                   239769_at     CDH11[\*](#nt105){ref-type="table-fn"}                            Cadherin 11, type 2, OB-cadherin (osteoblast)                                3.00
                 207173_x\_at    CDH11[\*](#nt105){ref-type="table-fn"}                            cadherin 11, type 2, OB-cadherin (osteoblast)                                2.85
                   205911_at                      PTHR1                                                   parathyroid hormone receptor 1                                        4.29
                   206772_at                      PTHR2                                                   parathyroid hormone receptor 2                                        −1.59
  Osteoclasts    202450_s\_at                     CTSK                                                              cathepsin K                                                 4.04
                 1554503_a\_at                    OSCAR                                         osteoclast associated, immunoglobulin-like receptor                             −1.28
                 207886_s\_at    CALCR[\*](#nt105){ref-type="table-fn"}                                         calcitonin receptor                                             1.59
                 207887_s\_at    CALCR[\*](#nt105){ref-type="table-fn"}                                         calcitonin receptor                                             1.04
                   204638_at                      ACP5                                                acid phosphatase 5, tartrate resistant                                    2.03

FC, fold change.

\*Multiple probe sets.

10.1371/journal.pone.0010692.t004

###### The validation of the array data was carried out by qRT-PCR of select number of transcripts for equal number of iliac crest (ILC) and lumbar spine (LS) samples (n = 5).

![](pone.0010692.t004){#pone-0010692-t004-4}

  Gene      Affymetrix Absolute Fold Change (ILC vs. LS)   qRT-PCR RQ (ILC vs. LS)
  -------- ---------------------------------------------- -------------------------
  COL1A1                        −7.2                                −22.8
  SOST                          −53                                 −90.7
  DMP1                          −42                                 −33.0
  MEPE                         −23.5                                −40.7
  CTSK                          −8.2                                −15.8
  ZIC1                         −86.7                                −666
  PTHR2                         1.5                                  1.7
  OSCAR                         1.7                                  1.4

Pathways analysis and novel gene identification {#s2c}
-----------------------------------------------

The differential analysis revealed that the top three pathways, i.e., with the highest number of differentially expressed transcripts, were TNF receptor signaling pathway, BMP signaling and Proteogylcan syndecan-mediated signaling ([Tables S3](#pone.0010692.s003){ref-type="supplementary-material"} to [S6](#pone.0010692.s006){ref-type="supplementary-material"}; [Figures 1](#pone-0010692-g001){ref-type="fig"}, [2](#pone-0010692-g002){ref-type="fig"}, & [3](#pone-0010692-g003){ref-type="fig"}). The details of the gene transcripts for the signaling mediated by TNF receptor, BMP and Proteogylcan syndecan-mediated pathway ([Figures 1](#pone-0010692-g001){ref-type="fig"}, [2](#pone-0010692-g002){ref-type="fig"} & [3](#pone-0010692-g003){ref-type="fig"}) is given in [Tables S4](#pone.0010692.s004){ref-type="supplementary-material"}, [S5](#pone.0010692.s005){ref-type="supplementary-material"} and [S6](#pone.0010692.s006){ref-type="supplementary-material"}, respectively. The majority of the post-receptor transcripts of these pathways were found to show up-regulation in the LS when compared with ILC. The analysis also reveals a number of hitherto unidentified and unknown transcripts which are involved in the signaling.

![TNF receptor signaling in trabecular bone.\
Direct interaction network models were constructed by Pathway Architect analysis of the differentially expressed transcript in the lumbar spine and iliac crest trabecular bone. Up-regulated transcripts are indicated red whilst the down-regulated are shown in green. Arrows link interacting genes and positive (+) and negative (−) associations are marked respectively. Green boxes denote regulation, blue boxes binding and orange circles indicating phosphorylation.](pone.0010692.g001){#pone-0010692-g001}

![BMP signaling in trabecular bone.\
In this interaction network model, constructed by Pathway Architect analysis software of differential expressed genes between iliac crest and the lumbar spine, up-regulated transcripts are indicated red whilst the down-regulated are shown in green. Arrows link interacting genes and positive (+) and negative (−) associations are marked respectively. Green boxes denote regulation, blue boxes binding and orange circles indicating phosphorylation.](pone.0010692.g002){#pone-0010692-g002}

![Proteogylcan Syndecan-mediated signaling in trabecular bone.\
Direct interaction network models constructed by Pathway Architect analysis of the differentially expressed transcript in the lumbar spine and iliac crest trabecular bone. Up-regulated transcripts are indicated red whilst the down-regulated are shown in green. Arrows link interacting genes and positive (+) and negative (−) associations are marked respectively. Green boxes denote regulation, blue boxes binding and orange circles indicating phosphorylation.](pone.0010692.g003){#pone-0010692-g003}

Probesets with a 5-fold or more change in expression were analysed with Ingenuity Pathway Analysis (IPA), a list of 268 eligible entities for IPA analysis. The most significant biological function classification was in skeletal and muscular development and function with the most significant subclass being skeletal development (corrected p-value of 2.22×10^−9^) ([Table S7](#pone.0010692.s007){ref-type="supplementary-material"}). Network analysis of the data set suggested one interaction network with skeletal and muscular system development and function including the genes Akt, COL1A1, CTGF, EGFR, EGR1, ERK, IGFBP3, ITGA4, Jnk, MYH11, NF-kB, (complex), PDGFBB, PI3K, Pka, POSTN, PTPRK, SOX9, SPARC, TGFB2, TIMP3 ([Figure 4](#pone-0010692-g004){ref-type="fig"}).

![Network enriched for genes involved in skeletal system.\
Molecules are represented as nodes, and the biological relationship between two nodes is represented as an edge (line). The intensity of the node color indicates the degree of down- (red) or up- (green) regulation where lumbar spine is compared with iliac crest. Nodes are displayed using various shapes that represent the functional class of the gene product. Direct relationships are shown in solid arrows, indirect relationships in dashed arrows. Genes with no colour are added to the network by Ingenuity Pathway Analysis as part of the network generation algorithm.](pone.0010692.g004){#pone-0010692-g004}

Discussion {#s3}
==========

The global transcriptosome first ever analysis of human lamellar LS and ILC revealed that whilst most of the transcripts showed a similar level of expression, a limited number of functionally associated subsets showed marked anatomical site-related differences. Interestingly, between L2, L3 and L4 vertebrae from different subjects there was a higher overall molecular homogeneity when compared with ILC from the same person. Therefore for further comparison the three vertebrae were treated as one group. Similarly, high degree of overall molecular homogeneity in gene expression was seen between symmetrical sites in ILC [@pone.0010692-Reppe1] underscoring the importance of function as a major determinant of bone cell gene expression .and adaptability. The number of gene transcripts and the extent of their up-regulation was much higher in the lamina of spinal vertebra when compared with ILC. The analysis of up-regulated genes showed that these were related to changes in key cellular and molecular components and strongly associated with essential biological functions in bone. The gene transcripts, reflecting respective transcriptional activities of osteocytes, osteoblasts and osteoclasts from vertebrae when compared with ILC, were found to be consistently up-regulated in the vertebrae and magnitude of the increased expression was quite similar. In contrast, the gene transcripts that reflect osteocytes, osteoblasts and osteoclasts number showed insignificant or less marked skeletal site-related variation. This conclusion was based on an analysis of the data evaluating osteocyte-, osteoblast- and osteoclast-specific structural transcripts, namely podoplanin in osteocytes, parathyroid hormone receptor in osteoblasts and osteocytes and calcitonin receptor and osteoclast-associated receptor in osteoclasts. We postulate that these transcripts provide estimate of the cell numbers with the reasonable assumption that each cell type in vertebra and ILC express on average similar number of the marker molecules. Since these transcripts were found to show only minor differences in vertebra and ILC when compared with other activity related transcripts ([Table 3](#pone-0010692-t003){ref-type="table"} & [4](#pone-0010692-t004){ref-type="table"}), we interpret that the observed increase in the respective activities of the three bone cell types were predominantly due to increase in the relative cell activity rather than reflecting a change in absolute cell number. Interestingly, the most profound up-regulation in the spinal vertebrae was observed for transcripts reflecting osteocyte activity, namely in SOST, DMP1, and MEPE.

In light of the recent observations, the data analysis allows us to suggest possible mechanisms for the existing evidence of increased bone turnover, based on the described molecular differences in osteoblast- and osteoclast-related bone remodelling in lamellar bone of LS when compared with ILC. It is generally accepted that mechanical stress induced by weight-bearing exercise increases osteoblast activity, and that the absence of mechanical stimulation resulting from prolonged immobilization or microgravity causes severe bone loss [@pone.0010692-Lorentzon1], [@pone.0010692-Semb1]. In recent years a number of observations suggest, based on *in vitro* studies and animal transgenic models, that osteocytes act as mechano-sensory cells and that lacuno-canaliculi carry signaling molecules that are responsible for maintenance of bone structure and mass [@pone.0010692-Zerath1]. Osteocytes are interconnected by a network that involves their dendritic processes within lacunae to osteoblasts; that mirrors the CNS neuronal network, but comprehensive identity of all relevant signaling molecules in bone remains to be identified [@pone.0010692-Bonewald1], [@pone.0010692-Datta1]. We believe that the present data show that osteocytes are more metabolically active than hitherto understood and play a central role in the determination and maintenance of bone structure [@pone.0010692-Bonewald1]--[@pone.0010692-Zhao1]. The bone matrix secludes and isolates osteocytes which have an extensive interaction and also connect to other surrounding cells via an elaborate network of dendritic processes which may have the potential to modulate bone resorption [@pone.0010692-Zhao1].

We hypothesize that significantly higher transcriptional activity within specific functional osteocyte networks in the spinal vertebra, when compared with ILC, is reflective of the increased stress experienced at the LS [@pone.0010692-Mannion1]. The mechanical stress, both due fluid shear stress and tissue strain, in bone is now thought to be mainly detected by osteocytes ([Figure 5](#pone-0010692-g005){ref-type="fig"}) [@pone.0010692-Bonewald1]--[@pone.0010692-Bonewald2]. Osteocytes are involved in mechano-sensing as well as in mechano-transduction of the stress into biochemical signal [@pone.0010692-Bonewald1]--[@pone.0010692-Bonewald2]. The increased expression of osteocyte-related transcripts, such as SOST, DMP1, MEPE, in the spine relative to the ILC, provides for the first time evidence of mechanical stress-related *in vivo* increase in osteocyte transcriptional activity. The osteocyte activity, resulting from excess mechanical loading, increases the respective activities of osteoblasts and osteoclasts, as evident from increase in the expression of matrix proteins (COL1A, SPARC, and IBSP) and osteoclast-specific enzymes (CTSK and ACP5) ([Table 3](#pone-0010692-t003){ref-type="table"} & [4](#pone-0010692-t004){ref-type="table"}; [Figure 5](#pone-0010692-g005){ref-type="fig"}). These genes, i.e., characteristically associated with osteocyte, osteoblasts and osteoclasts, showing markedly increased expression, encode secretory proteins. Further evidence of skeletal site-related difference in the bone remodelling activity due to mechanical stress, that seem to be orchestrated by osteocyte, is provided by the PathwayArchitect™ analysis ([Figures 2](#pone-0010692-g002){ref-type="fig"}, [3](#pone-0010692-g003){ref-type="fig"} and [4](#pone-0010692-g004){ref-type="fig"}; Tables [S4](#pone.0010692.s004){ref-type="supplementary-material"}, [S5](#pone.0010692.s005){ref-type="supplementary-material"} and [S6](#pone.0010692.s006){ref-type="supplementary-material"}). The analysis shows that top pathways, in terms of differential expression in the lamina of LS as compared with the ILC, are those involved in the bone formation by osteoblasts (BMP signalling pathway, Proteoglycan Syndecan signalling) and bone-resorption by osteoclast (TNF receptor signalling, and other network groups, e.g. adherence/adhesion). The most likely explanation in the observed increase in transcriptional activity in the osteocyte, as well as osteoblasts and osteoclasts, in the spine is likely to be a higher degree of local mechanical stress [@pone.0010692-Mannion1]. The data presented provides support for the proposal that osteocytes modulate respective bone-formation and bone-resorptive activities of osteoblasts and osteoclasts, and thereby regulate and maintain of bone mass. These observations add to our understanding about the central role of osteocytes in the maintenance of bone mass in health and in the pathogenesis of osteoporosis.

![Role of osteocytes in mechanotransduction in trabecular bone.\
The increased mechanical stress is detected by mechanosensors, a function which is primarily performed by the osteocytes (∼90% of the total cell number). The increased mechanical stress is mechano-transduced into intracellular biochemical signals by osteocytes and results in increased transcriptional activity of range of genes (SOST, MEPE and DMP1). Osteocytes also transmute mechanical stress into intercellular biochemical signals to modulate the respective activities of the osteoclasts and osteoblasts.](pone.0010692.g005){#pone-0010692-g005}

The comparison of the relative expression of the transcripts led to identification of a number of novel and uncharacterised genes, whose function in bone cell biology is not yet known [@pone.0010692-Datta3], [@pone.0010692-Kalogeropoulos1]. In addition, the pathways analysis revealed the known key signaling molecules ([Figs. 1](#pone-0010692-g001){ref-type="fig"}, [2](#pone-0010692-g002){ref-type="fig"} & [3](#pone-0010692-g003){ref-type="fig"} and corresponding [Tables S4](#pone.0010692.s004){ref-type="supplementary-material"}, [S5](#pone.0010692.s005){ref-type="supplementary-material"} & [S6](#pone.0010692.s006){ref-type="supplementary-material"}), and led to the identification some novel pathways specific intracellular putative proteins. Further studies, such as cell protein expression, protein-protein interaction and knock-in and knock-out functional studies are required to establish the role of these novel proteins. In conclusion, taken together the data show that at the transcriptional level bone has a strong ability to adapt to functional demands, and osteocyte play a critical role in the process. The adaptive response involves "growth and developmental processes", probably made possible through their "high sensitivity to synaptic processes" and "matrix" engineering properties.

Methods {#s4}
=======

Subject selection {#s4a}
-----------------

The participants numbered thirteen Caucasian men who were all from North East England, U.K., who were undergoing spinal decompression laminectomies or spinal fusions of the LS. This study was conducted according to the principles expressed in the Declaration of Helsinki. The study was approved by the Institutional Review Board of Northumberland Local Research Ethics Committee, Blyth, Northumberland NE24 2AG (REC Reference: 04/Q0902/29), and all subjects gave their informed written consent. Underlying secondary causes of osteoporosis were excluded by medical history, physical examination and laboratory investigations. Men with a history of treatment with antiresoptive agents, steroid, anticonvulsant and anticoagulant were excluded [@pone.0010692-Aloanzi1] ([Text S1](#pone.0010692.s009){ref-type="supplementary-material"}). The mean±SD (range) of age, weight and height respectively were 53.9±10.7 (35.0-69.0)yr, 86.6±8.6 (84.0-108.2)kg and 176.4±6.3 (167.0-184)cm, respectively. The mean±SD (range) for BMD, given as areal density, for LS, total hip, and femoral neck respectively were 1.067±0.332 (0.760-1.387), 1.047±0.153 (0.820-1.271) and 0.870±0.153 (0.620-1.202) gm/cm^2^, respectively. None of the subjects had history of low trauma fractures ([Table S8](#pone.0010692.s008){ref-type="supplementary-material"} and [Text S1](#pone.0010692.s009){ref-type="supplementary-material"}).

All bone biopsies were trabecular and taken from a specific site in the ILC site, 2 cm backwards from the anterior superior iliac spine. Further consistency was achieved by ensuring that only one senior surgeon supervised all biopsies with explicit instructions to avoid attached tissues, specifically muscle. Similarly spinal biopsies were all trabecular and all were from lamina processes of the lumbar vertebrae two, three and four. A total of 24 biopsies were obtained for analysis from 13 men, 19 from the lamina of the LS and 5 from the ILC.

Biochemical and BMD measurements {#s4b}
--------------------------------

Serum testosterone, sex-hormone-binding globulins, follicular stimulating hormone and luteinizing hormone were measured by commercially available radioimmunoassays (SAS laboratory, Royal Victoria Infirmary, Newcastle upon Tyne). All bone density measurements were performed by DXA using a Hologic QDR 2000 Bone Densitometer (Hologic, Waltham, MA). In vivo precision for measurement with this system is 1.0% at the LS (L1-L4) and 1.5% for the femoral neck. BMD results were obtained as an areal density in g/cm^2^, but were also given as T- and Z- scores. The T-score is the number of standard deviation units above or below the mean for normal young men, whilst the Z-score is the number of standard deviation units above or below the age-related normal men (calculated using the manufacturer\'s standard normal reference database). The results of laboratory investigations for all these subjects were within normal laboratory ranges.

Extraction of RNA {#s4c}
-----------------

The trabecular bone from the laminar and ILC that were excess to the surgical requirement were collected as biopsies of size approximately 0.25 to 1 cm^3^. The biopsies were immediately frozen and stored in liquid nitrogen for later extraction of RNA. The frozen bone biopsies were pulverized with a mortar in liquid nitrogen with their content of marrow intact. RNA was then extracted by homogenization in Trizol (Life Technologies, Invitrogen, cat no 15596) 1 ml/100 mg, then following the manufacturers procedure. RNA was further purified using the RNeasy kit (Qiagen) to remove organic components and finally re-suspended in RNAse free deionsed water and quantified using the Nanodrop spectrophotometer. The total RNA integrity was checked using Agilent 2100 BioAnalyzer (Agilent Technologies, Inc.) prior to cDNA synthesis. In addition, the quality of the RNA was controlled according to the Affymetrix test manual by measuring the ratio between 3′ and 5′ end for GAPDH mRNA (ratio always\<2.0)

Microarray analysis {#s4d}
-------------------

Double-stranded cDNA and biotin-labeled cRNA probes were made from 5 µg total RNA using the Superscript Choice system (Invitrogen) and the Enzo Bioarray respectively. Procedures were performed according to recommendations from Affymetrix [@pone.0010692-Reppe1], [@pone.0010692-Kalogeropoulos1]. This cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 Array containing cDNA oligonucleotides representing more than 54,000 probe sets for 38,000 different genes followed by washing and staining on the GeneChips Fluidics Station 450 (Affymetrix) according to manufacturer\'s instructions. The chips were scanned on the Affymetrix GeneChip® 3000 scanner. The quality of the RNA and probe was controlled by an Affymetrix based test measuring the ratio between 5′ and 3′ mRNAs for β-actin and GAPDH and found to be highly satisfactory. The datasets originating from the specimens were first processed by the Affymetrix Mas5.0 software, and signal values representing the expression level of each transcript were generated. Each sample was normalized as recommended by Affymetrix by multiplying all signal values with a scaling factor that results in an average signal value of 500 for all genes that are classified as "present" calculated by the Affymetrix MAS 5.0 program. The scaling factor is set by examining all the probe sets on the array to compute a trimmed mean signal and derive a scale factor for the array so that: Target signal  =  Scale factor × Trimmed mean signalprobe array. Thus, the scale factor standardizes the trimmed mean signal of the array to the target signal. The patients were coded, and all analyses were carried out blindly. Both samples from each patient were analyzed in the same kit for cRNA probe synthesis and hybridized to chips from the same batch. One chip was used for each sample (cRNA synthesis) as the variability between chips and cRNA syntheses is significantly lower than the potential variability derived from different biological samples.

Data Analysis {#s4e}
-------------

The overview of differentially expressed genes in the LS relative to ILC in male controls was generated by the use of Affymetrix software, which made it possible to compare data from two arrays. The statistical analysis is based on 22 different cDNA oligonucleotides to measure quantitatively one mRNA transcript, and each cDNA probe is distributed as 22 different "micro-spots". Thus, 22 signals for each mRNA transcript (probeset) are generated and enables the Affymetrix software GCOS to compute p-values for differential expression when two transcripts on two different arrays are compared. The Wilcoxon\'s Signed Rank test uses the differences between Perfect Match and Mismatch probe signal intensities, as well as the differences between Perfect Match intensities and background to compute each p-value difference. From Wilcoxon\'s Signed Rank test, a total of three, one-sided p-values are computed for each probe set. The most conservative value is chosen to determine the "change call". That is the value closest to 0.5 signifying that no change is detected. These are combined to give one final p-value.

Data from HGU-1333 plus 2 Affymetrix GeneChip arrays was imported into GeneSpring GX 11 and summarised and normalised with MAS5 and GC-RMA. Flag data from the MAS5 analysis was used to derive a probeset list where at least 19 out of 25 samples had a present or marginal call. This left 20796 probesets, which was further reduced to 20764 probesets after Affymetrix control probesets were removed from the list. This list was used for all downstream statistical analysis. An unpaired t-test between LS and ILC samples was used to detect differential expression. Probesets reported as being differentially expressed if they satisfy a corrected p-value cutoff of \<0.05 when performing multiple testing correction with Benjamini-Hochberg False Discovery Rate (FDR).

Pathway analysis was also carried out with Ingenuity Pathway Analysis 8.5 (Ingenuity Systems <http://www.ingenuity.com>) on probesets differentially expressed in lumbar and ILC biopsies. Canonical pathways analysis identified the pathways from the Ingenuity library of pathways that were most significant to the data set. The significance of the association between the data set and the canonical pathway was measured in 2 ways: 1) A ratio of the number of molecules from the data set that map to the pathway divided by the total number of molecules that map to the canonical pathway is displayed. 2) Fisher\'s exact test was used to calculate a p-value determining the probability that the association between the genes in the dataset and the canonical pathway is explained by chance alone.

Affymetrix identifiers and fold change information was loaded into IPA and each identifier was mapped to its corresponding object in Ingenuity\'s Knowledge Base. A 5-fold cutoff of fold change was set to identify molecules whose expression was significantly differentially regulated. These molecules, called Network Eligible molecules, were overlaid onto a global molecular network developed from information contained in Ingenuity\'s Knowledge Base. Networks of Network Eligible Molecules were then algorithmically generated based on their connectivity. The Functional Analysis of a network identified the biological functions and/or diseases that were most significant to the molecules in the network. The network molecules associated with biological functions and/or diseases in Ingenuity\'s Knowledge Base were considered for the analysis. Right-tailed Fisher\'s exact test was used to calculate a p-value determining the probability that each biological function and/or disease assigned to that network is due to chance alone. All edges of the pathways generated are supported by at least one reference from the literature, from a textbook, or from canonical information stored in the Ingenuity Pathways Knowledge Base. Human, mouse, and rat orthologs of a gene are stored as separate objects in the Ingenuity Pathways Knowledge Base, but are represented as a single node in the network.

ArrayAssist (Stratagene) was further used to created a raw data set and identify differential gene expression. The change in relative expression of the remaining set of transcripts was assessed using t-tests with Benjamin-Hochberg (false discovery rate, FDR) correction (2-fold minimum cut-off and p\<0.05). These transcripts, i.e., showing FC≥2 in bone biopsies taken from ILC and LS, were further analysed by PathwayArchitect™ software (Stratagene). This analysis utilizes existing relevant literature for pathway analysis and visualization and permits identification of shared common direct regulators or downstream targets. PathwayArchitect™ analysis software can identify gene-gene interaction, gene regulation and their key functions in the complex pathways.

The guidelines described in MIAME (Minimal Information About a Microarray Experiment) has been followed in writing this paper. The primary data has been submitted to the European Bioinformatics Institute (EMBL-EBI) ArrayExpress repository. The experiment name is "Skeletal Site-Related Variation in Human Bone Transcriptome" and Signalling ArrayExpress accession number is: E-MEXP-2219.

Quantitative RT-PCR {#s4f}
-------------------

The Affymetrix gene expression data were validated for selected transcripts using the TaqMan gene expression assays and the Applied Biosystems Prism 7900 HT sequence detection system. Five 500 ng total RNA from each donor was reverse transcribed using Omniscript (Qiagen Ltd.), and cDNA representing 2.5 ng total RNA was used in each PCR reaction. The PCR reactions were run in duplicates. The relative changes of each transcript, using GAPDH (glyceraldehyde-3-phosphate dehydrogenase) as endogenous control, were calculated using the 2(ΔΔC(T) method [@pone.0010692-Livak1], and the gene expression results are given as RQ (relative quantitation).

Supporting Information {#s5}
======================

###### 

Anatomical-site related comparison of overall molecular homogeneity between different skeletal sites.

(0.01 MB .DOCX)

###### 

Click here for additional data file.

###### 

Examination of Gene Ontology (GO) terms shows an overrepresentation for a number of GO terms (p\<0.005) including cell adhesion, extracellular matrix formation and skeletal development.

(0.03 MB XLS)

###### 

Click here for additional data file.

###### 

Top 30 signalling pathways identified by comparing differential transcript expression in the lumbar spine versus iliac crest (4244 gene transcripts with FC ≥2, p-value ≤0.05).

(0.06 MB DOC)

###### 

Click here for additional data file.

###### 

TNF receptor signalling pathway gene transcripts identification based on differential expression in lamina lumbar spine and iliac crest; the analysis was carried out using Pathway Architect Software and the pathway generated is shown in [Fig. 2](#pone-0010692-g002){ref-type="fig"}.

(0.06 MB DOC)

###### 

Click here for additional data file.

###### 

BMP signalling pathway gene transcripts identification based on the differential expression in iliac crest and in the lamina of lumbar spine; the analysis was carried out using Pathway Architect Software and the pathway generated is shown in [Fig. 3](#pone-0010692-g003){ref-type="fig"}.

(0.06 MB DOC)

###### 

Click here for additional data file.

###### 

Proteoglycan Syndecan signalling events identification based on analysis of differential expression in the lamina of lumbar spine and iliac crest; the analysis was carried out using Pathway Architect Software and the pathway generated is shown in [Fig. 4](#pone-0010692-g004){ref-type="fig"}.

(0.06 MB DOC)

###### 

Click here for additional data file.

###### 

Probesets with a 5-fold or more change in expression were analysed with Ingenuity Pathway Analysis (IPA), a list of 268 eligible entities for IPA analysis. The most significant biological function classification was in skeletal and muscular development and function.

(0.04 MB XLS)

###### 

Click here for additional data file.

###### 

Anthropometric indices age and bone density of individual subjects.

(0.05 MB DOC)

###### 

Click here for additional data file.

###### 

Details of clinical evaluation, including medical history and laboratory investigations, used for the subject selection.

(0.04 MB DOC)

###### 

Click here for additional data file.
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